Share-based Compensation

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

12. SHARE-BASED COMPENSATION

The following table presents share-based compensation expense included in the accompanying condensed consolidated statements of operations and comprehensive income (loss):


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In thousands)	2023		2022		2023		2022
Cost of goods manufactured and sold	$	2,939	$	2,623	$	8,542	$	7,406
Research and development		7,208		6,858		21,621		19,688
Selling, general and administrative		13,768		16,570		44,899		40,677
Total share-based compensation expense	$	23,915	$	26,051	$	75,062	$	67,771

At September 30, 2023 and December 31, 2022, $3.2 million and $3.3 million, respectively, of share-based compensation expense was capitalized and recorded as “Inventory” in the accompanying condensed consolidated balance sheets.

On June 29, 2023, the Company’s shareholders approved an amended version of the Alkermes plc 2018 Stock Option and Incentive Plan that served to, among other things, increase the number of ordinary shares authorized for issuance thereunder by 6,500,000.